Medistim

Earnings Release • Aug 19, 2015

Results for the second quarter and first half of 2015 for Medistim ASA

Results for the second quarter and first half of 2015 for Medistim ASA

Sales ended at MNOK 57.3 for the quarter (MNOK

47.9), a 19.6 % growth. Sales for the 1st half

increased by 19.1 % and ended at MOK 115.2 (MNOK

96.7). Operating profit (EBIT) for the quarter ended

at MNOK 11.7 (MNOK 11.7) after an accrual of MNOK

3.2 related to termination of the Medtronic

agreement. Operating profit for the 1st half ended

at MNOK 21.6 (MNOK 18.9). Profit per share increased

with 45 % for the quarter and ended at NOK 0.58 (NOK

0.40)

There was a positive development in USA with 40 %

increase in sales in the 2nd quarter and 45 % for

the first half. Medistim strengthens it US operation

by increasing its sales force. Medistim is

sponsoring REQUEST, a pioneer multicenter register

study performed by leading hospitals in Europe and

North.

Dividend based upon 2014 results was paid in the 2nd

quarter with MNOK 25.3, NOK 1.40 per share (NOK 0.80

per share).